Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.86 USD | -0.74% | -2.15% | +196.80% |
Evolution of the average Target Price on Avidity Biosciences, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Avidity Biosciences, Inc.
Cantor Fitzgerald | |
Chardan Research | |
Evercore ISI | |
Wells Fargo Securities | |
Credit Suisse | |
Raymond James | |
SVB Securities LLC | |
SVB Leerink | |
Needham & Co. |
EPS Revisions
- Stock Market
- Equities
- RNA Stock
- Consensus Avidity Biosciences, Inc.